Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Global Breast Cancer Market Report: 2013 Edition- Koncept Analytics

Global Breast Cancer Market Report: 2013 Edition- Koncept Analytics

Ratings: (0)|Views: 30|Likes:
Published by Koncept Analytics
Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing on account of changing lifestyle and incessantly evolving surroundings. To cater to the necessity of better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostic technologies and treatment therapies, especially in the field of breast cancer treatment.
‘Cancer’ is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cells and keeping them healthy. The tumor formed due to cancer can be either ‘benign’ (not dangerous) or ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells of the lobules (milk-producing glands), or the ducts (the passages that drain milk from the lobules to the nipple).
The stages of breast cancer are crucial as they only determine the type of treatment method and the extent to which the disease can be cured. On the diagnosis front, mammography is believed to diagnose 85% to 90% of breast cancers in women over 50, and is capable of discovering a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images; therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by hormone therapy, chemo therapy or radiation therapy.
After lung cancer, breast cancer is the 2nd most prevalent type of cancer and 5th most common cause of cancer deaths on global scale. Over one million new cases of breast cancer are diagnosed every year world over.
The present report offers a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, India and Brazil including the revenue build of two major drugs in the coming years. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules, diagnostics technology application and pricing of the product. The leading players operating in the industry include Hologic, J&J and Siemens AG which are also profiled in this report.
Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing on account of changing lifestyle and incessantly evolving surroundings. To cater to the necessity of better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostic technologies and treatment therapies, especially in the field of breast cancer treatment.
‘Cancer’ is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cells and keeping them healthy. The tumor formed due to cancer can be either ‘benign’ (not dangerous) or ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells of the lobules (milk-producing glands), or the ducts (the passages that drain milk from the lobules to the nipple).
The stages of breast cancer are crucial as they only determine the type of treatment method and the extent to which the disease can be cured. On the diagnosis front, mammography is believed to diagnose 85% to 90% of breast cancers in women over 50, and is capable of discovering a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images; therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by hormone therapy, chemo therapy or radiation therapy.
After lung cancer, breast cancer is the 2nd most prevalent type of cancer and 5th most common cause of cancer deaths on global scale. Over one million new cases of breast cancer are diagnosed every year world over.
The present report offers a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, India and Brazil including the revenue build of two major drugs in the coming years. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules, diagnostics technology application and pricing of the product. The leading players operating in the industry include Hologic, J&J and Siemens AG which are also profiled in this report.

More info:

Categories:Types, Research
Published by: Koncept Analytics on Jun 28, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

11/09/2013

pdf

text

original

 
Global Breast Cancer Market
---------------------------------------------
2013
 
Executive Summary
Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmountingnew acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing onaccount of changing lifestyle and incessantly evolving surroundings. To cater to the necessity of better healthcare options and theunmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostictechnologies and treatment therapies, especially in the field of breast cancer treatment.
„Cancer‟
is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cellsand keeping them healthy. The tumor formed due to cancer can be either 
„benign‟
(not dangerous) or 
„malignant‟
(potentiallydangerous).
„Breastcancer‟
is a malignant tumor that has developed from cells in the breast. Typically breast cancer either beginsin the cells of the lobules (milk-producing glands), or the ducts (the passages that drain milk from the lobules to the nipple).The stages of breast cancer are crucial as they only determine the type of treatment method and the extent to which the diseasecan be cured. On the diagnosis front, mammography is believed to diagnose 85% to 90% of breast cancers in women over 50,and is capable of discovering a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue,breast implants or patients who are breastfeeding, mammography cannot produce clear images; therefore, in such cases,ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by hormone therapy, chemo therapy or radiationtherapy. After lung cancer, breast cancer is the 2nd most prevalent type of cancer and 5th most common cause of cancer deaths on globalscale. Over one million new cases of breast cancer are diagnosed every year world over.The present report offers a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus onregions like the US, India and Brazil including the revenue build of two major drugs in the coming years. Furthermore, marketdynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry areelicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules, diagnostics technology application and pricing of the product. The leading players operating in theindustry include Hologic, J&J and Siemens AG which are also profiled in this report.
 
Any mutation or abnormal change in the genes accountable for regulating the growth of cells and keeping
them healthy causes ‘Cancer’. ‘Breast cancer’ defines a malignant tumor that has developed from cells in
the breast.
The oncology sales were worth US$........billion in 2011 which ispoised to reach US$.......... billion by 2014.
 As of 2011, the breast cancer therapeutics market in the major countries including the US, the UK, Germany, France, Italy, Spain,Japan, Brazil, Russia, India, and China, collectively was worthUS$......... billion, growing at a CAGR of 
…………
..% since 2000. Therevenues generation by the respective industry is likely to reachUS$........... billion by 2020.
IndustryTrendsandDevelopments
-Successive Clinical Trials and Product Development
GrowthDrivers
-Increasing Prevalence of Cancer -Increasing Use of Tobacco and Alcohol-Expanding Obese Population-Rising Demand for Better Healthcare Options-Growing Female Population (+45 Years)-Higher Spending on Medicines 36
Challenges
-Rising Costs of Treatment-Stringent Regulatory Measures-Adverse Effects of the Treatment-Mounting Price Pressure
Global Oncology Sales (2009-2014E)Breast Cancer Therapeutics Market (2011 and 2020E)
2009 2010 2011 2012E 2013E 2014E
   U   S   $   B   i   l   l   i  o  n
2011 2020E
   U   S   $   B   i   l   l   i  o  n

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->